219 related articles for article (PubMed ID: 28427099)
1. Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants.
Hernández-Ramírez LC; Trivellin G; Stratakis CA
Horm Metab Res; 2017 Apr; 49(4):286-295. PubMed ID: 28427099
[TBL] [Abstract][Full Text] [Related]
2. cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors.
Bolger GB; Bizzi MF; Pinheiro SV; Trivellin G; Smoot L; Accavitti MA; Korbonits M; Ribeiro-Oliveira A
Endocr Relat Cancer; 2016 May; 23(5):419-31. PubMed ID: 27267386
[TBL] [Abstract][Full Text] [Related]
3. Reduced protein expression of the phosphodiesterases PDE4A4 and PDE4A8 in AIP mutation positive somatotroph adenomas.
Bizzi MF; Pinheiro SVB; Bolger GB; Schweizer JROL; Giannetti AV; Dang MN; Ribeiro-Oliveira A; Korbonits M
Mol Cell Endocrinol; 2018 Nov; 476():103-109. PubMed ID: 29729370
[TBL] [Abstract][Full Text] [Related]
4. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A; Aaltonen LA; Daly AF; Karhu A
Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
[TBL] [Abstract][Full Text] [Related]
5. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
6. Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.
Schernthaner-Reiter MH; Trivellin G; Roetzer T; Hainfellner JA; Starost MF; Stratakis CA
Hum Mol Genet; 2020 Oct; 29(17):2951-2961. PubMed ID: 32821937
[TBL] [Abstract][Full Text] [Related]
7. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
Pepe S; Korbonits M; Iacovazzo D
J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
[TBL] [Abstract][Full Text] [Related]
8. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L
Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of the aip gene in familial pituitary tumorigenesis.
Tahir A; Chahal HS; Korbonits M
Prog Brain Res; 2010; 182():229-53. PubMed ID: 20541668
[TBL] [Abstract][Full Text] [Related]
10. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Daly AF; Beckers A
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A
PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362
[TBL] [Abstract][Full Text] [Related]
12. Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).
Schernthaner-Reiter MH; Trivellin G; Stratakis CA
Hum Mol Genet; 2018 Aug; 27(15):2604-2613. PubMed ID: 29726992
[TBL] [Abstract][Full Text] [Related]
13. AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling.
Tuominen I; Heliövaara E; Raitila A; Rautiainen MR; Mehine M; Katainen R; Donner I; Aittomäki V; Lehtonen HJ; Ahlsten M; Kivipelto L; Schalin-Jäntti C; Arola J; Hautaniemi S; Karhu A
Oncogene; 2015 Feb; 34(9):1174-84. PubMed ID: 24662816
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
[TBL] [Abstract][Full Text] [Related]
15. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.
Foltran RK; Amorim PVGH; Duarte FH; Grande IPP; Freire ACTB; Frassetto FP; Dettoni JB; Alves VA; Castro I; Trarbach EB; Bronstein MD; Jallad RS
Braz J Med Biol Res; 2018 Jun; 51(9):e7427. PubMed ID: 29947650
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
[TBL] [Abstract][Full Text] [Related]
17. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability.
Vargiolu M; Fusco D; Kurelac I; Dirnberger D; Baumeister R; Morra I; Melcarne A; Rimondini R; Romeo G; Bonora E
J Clin Endocrinol Metab; 2009 Jul; 94(7):2571-8. PubMed ID: 19366855
[TBL] [Abstract][Full Text] [Related]
19. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
[TBL] [Abstract][Full Text] [Related]
20. RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas.
Garcia-Rendueles AR; Chenlo M; Oroz-Gonjar F; Solomou A; Mistry A; Barry S; Gaston-Massuet C; Garcia-Lavandeira M; Perez-Romero S; Suarez-Fariña M; Pradilla-Dieste A; Dieguez C; Mehlen P; Korbonits M; Alvarez CV
Oncogene; 2021 Nov; 40(45):6354-6368. PubMed ID: 34588620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
